HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bi-Yuan Zheng Selected Research

Neoplasms (Cancer)

2/2023A Sulfur-Bridging Sulfonate-Modified Zinc(II) Phthalocyanine Nanoliposome Possessing Hybrid Type I and Type II Photoreactions with Efficient Photodynamic Anticancer Effects.
9/2022Thermosensitive Liposomal Nanoplatform Based on Metal-Free Phthalocyanine with Copper(II)-Regulated Photoactivities.
6/2022Molecular and Supramolecular Approach to Highly Photocytotoxic Phthalocyanines with Dual Cell Uptake Pathways and Albumin-Enhanced Tumor Targeting.
1/2021Nanostructured Phthalocyanine Assemblies with Efficient Synergistic Effect of Type I Photoreaction and Photothermal Action to Overcome Tumor Hypoxia in Photodynamic Therapy.
1/2021A phthalocyanine-based self-assembled nanophotosensitizer for efficient in vivo photodynamic anticancer therapy.
1/2021A pH-sensitive nanoagent self-assembled from a highly negatively-charged phthalocyanine with excellent biosafety for photothermal therapy.
12/2020A non-aggregated zinc(II) phthalocyanine with hexadeca cations for antitumor and antibacterial photodynamic therapies.
11/2020Artesunate-Based Multifunctional Nanoplatform for Photothermal/Photoinduced Thermodynamic Synergistic Anticancer Therapy.
1/2020Noncovalent Indocyanine Green Conjugate of C-Phycocyanin: Preparation and Tumor-Associated Macrophages-Targeted Photothermal Therapeutics.
10/2019Size-Tunable Targeting-Triggered Nanophotosensitizers Based on Self-Assembly of a Phthalocyanine-Biotin Conjugate for Photodynamic Therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bi-Yuan Zheng Research Topics

Disease

20Neoplasms (Cancer)
02/2023 - 10/2013
2Phototoxic Dermatitis (Phototoxicity)
06/2022 - 01/2017
1Hepatocellular Carcinoma (Hepatoma)
02/2018
1Melanoma (Melanoma, Malignant)
02/2018

Drug/Important Bio-Agent (IBA)

61-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2020 - 01/2017
3Photosensitizing Agents (Photosensitizers)IBA
12/2018 - 10/2013
2Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 11/2020
1SolutionsIBA
02/2023
1ZincIBA
02/2023
1AlbuminsIBA
06/2022
1LigandsIBA
01/2021
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2021
1artemisinin (artemisinine)IBA
11/2020
1cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2020
1biotin receptorIBA
10/2019
1Silicon Dioxide (Silica)FDA LinkGeneric
12/2018
1copper phthalocyanine (phthalocyanine blue)IBA
02/2018
1Rose BengalIBA
02/2018
1ProdrugsIBA
02/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2017
1phthalocyanineIBA
02/2017

Therapy/Procedure

5Therapeutics
09/2022 - 01/2015
4Photochemotherapy (Photodynamic Therapy)
12/2018 - 01/2017
2Intravenous Injections
02/2023 - 01/2021
2Photothermal Therapy
01/2021 - 02/2018
1Phototherapy (Light Therapy)
06/2022
1Intravenous Administration
12/2018
1Intralesional Injections
02/2018